Flortaucipir f-18 - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for flortaucipir f-18 and what is the scope of patent protection?
Flortaucipir f-18
is the generic ingredient in one branded drug marketed by Avid Radiopharms Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Flortaucipir f-18 has twenty-seven patent family members in seventeen countries.
One supplier is listed for this compound.
Summary for flortaucipir f-18
| International Patents: | 27 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 21 |
| Patent Applications: | 15 |
| What excipients (inactive ingredients) are in flortaucipir f-18? | flortaucipir f-18 excipients list |
| DailyMed Link: | flortaucipir f-18 at DailyMed |
Recent Clinical Trials for flortaucipir f-18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tharick Pascoal | Phase 1 |
| Seelos Therapeutics, Inc. | Phase 2 |
| National Institute on Aging (NIA) | Phase 1 |
US Patents and Regulatory Information for flortaucipir f-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-003 | Jul 1, 2022 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-002 | May 28, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-001 | May 28, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-002 | May 28, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for flortaucipir f-18
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2013176698 | See Plans and Pricing | |
| Lithuania | 2247558 | See Plans and Pricing | |
| Colombia | 7131359 | Agentes de imagen para detectar disfunción neurológica | See Plans and Pricing |
| European Patent Office | 2852572 | AGENTS D'IMAGERIE À BASE DE CARBOLINE ET DE CARBAZOLE POUR LA DÉTECTION DE DYSFONCTION NEUROLOGIQUE (CARBOLINE AND CARBAZOLE BASED IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION) | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
